HaluGen Life Sciences’ test evaluates an individual’s overall sensitivity and risk profile associated with psychedelic-assisted therapy […]
Vancouver, British Columbia – June 9, 2021 – (CSE: IGLD, OTCQB:GIDMF, FRA:6NN) (the “Company” or “IGLD“) is pleased to announce it has completed its previously announced non-brokered private placement financing (the “Private Placement”) and has […]
FARMINGTON HILLS, Mich., June 04, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced it […]
Budd Hutt continues to pave the way to open the next store in Vermilion, Alberta in June 2021. […]
Vancouver, British Columbia–(Newsfile Corp. – June 3, 2021) – Golden Independence Mining Corp. (CSE: IGLD) (OTCQB: GIDMF) (FSE: 6NN) (the “Company” or “IGLD“) announces that it is proceeding with a non-brokered private placement (the “Private Placement“) […]
Poster highlighting proof-of-concept study of Citius’ iPSC-derived stem cell therapy in acute lung injury chosen for Best Poster Award at ISCT 2021 from among 336 posters selected from,400 abstracts submitted […]
Newly Issued Claims Extend Patent Protection to Year 2039 for Nyxol®Combination Therapy for Presbyopia […]
Vancouver, British Columbia–(Newsfile Corp. – May 18, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced it […]
Revenue up 34% and EPS up 4,391% to all-time record EPS of $0.002 and first profitable quarter in the Company’s most recent history […]
Launch of Psychedelics DNA Test Kit,
Phase 1 clinical trial for DMT progressing as planned,
Pre-clinical In Vivo work scheduled to start at Israeli CRO […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com